<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
  <head>
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
    		<meta name="keywords" content="Benign prostatic hyperplasia,Urologicals,Urologicals,5-alpha-reductase inhibitor,ATC code G04,Acetohydroxamic acid,Acidifier,Adrenergic receptor,Alfuzosin,Alpha blocker,Alprostadil" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (English)" />
		<link rel="copyright" href="../../../COPYING.html" />
    <title>Benign prostatic hyperplasia - Wikipedia, the free encyclopedia</title>
    <style type="text/css">/*<![CDATA[*/ @import "../../../skins/htmldump/main.css"; /*]]>*/</style>
    <link rel="stylesheet" type="text/css" media="print" href="../../../skins/common/commonPrint.css" />
    <!--[if lt IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE50Fixes.css";</style><![endif]-->
    <!--[if IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE55Fixes.css";</style><![endif]-->
    <!--[if IE 6]><style type="text/css">@import "../../../skins/monobook/IE60Fixes.css";</style><![endif]-->
    <!--[if IE]><script type="text/javascript" src="../../../skins/common/IEFixes.js"></script>
    <meta http-equiv="imagetoolbar" content="no" /><![endif]-->
    <script type="text/javascript" src="../../../skins/common/wikibits.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/md5.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/utf8.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/lookup.js"></script>
    <script type="text/javascript" src="../../../raw/gen.js"></script>        <style type="text/css">/*<![CDATA[*/
@import "../../../raw/MediaWiki%7ECommon.css";
@import "../../../raw/MediaWiki%7EMonobook.css";
@import "../../../raw/gen.css";
/*]]>*/</style>          </head>
  <body
    class="ns-0">
    <div id="globalWrapper">
      <div id="column-content">
	<div id="content">
	  <a name="top" id="contentTop"></a>
	        <h1 class="firstHeading">Benign prostatic hyperplasia</h1>
	  <div id="bodyContent">
	    <h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
	    <div id="contentSub"></div>
	    	    <div class="usermessage">You have <a href="../../../1/2/7/User_talk%7E127.0.0.1.html" title="User talk:127.0.0.1">new messages</a> (<a href="../../../1/2/7/User_talk%7E127.0.0.1.html" title="User talk:127.0.0.1">last change</a>).</div>	    <!-- start content -->
	    <table class="infobox" style="width: 200px; font-size: 95%; text-align: left;">
<caption style="background: lightgrey; font-size: 95%;"><b>Benign prostatic hyperplasia</b><br />
<i>Classification &amp; external resources</i></caption>
<tr>
<th><a href="../../../i/c/d/ICD_10d0.html" title="ICD">ICD</a>-<a href="../../../l/i/s/List_of_ICD-10_codes_1183.html" title="List of ICD-10 codes">10</a></th>
<td>N40</td>
</tr>
<tr>
<th><a href="../../../i/c/d/ICD_10d0.html" title="ICD">ICD</a>-<a href="../../../l/i/s/List_of_ICD-9_codes_cdaa.html" title="List of ICD-9 codes">9</a></th>
<td><a href="http://www.icd9data.com/getICD9Code.ashx?icd9=600" class="external text" title="http://www.icd9data.com/getICD9Code.ashx?icd9=600" rel="nofollow">600</a></td>
</tr>
</table>
<div class="dablink"><i>For other uses of the acronym BPH, see <a href="../../../b/p/h/BPH_%28disambiguation%29_429c.html" title="BPH (disambiguation)">BPH (disambiguation)</a>.</i></div>
<p><b>Benign prostatic hyperplasia</b> (<b>BPH</b>) also known as <b>Benign prostatic hypertrophy</b> or <b>Benign enlargement of the prostate (BEP)</b> refers to the increase in size of the <a href="../../../p/r/o/Prostate.html" title="Prostate">prostate</a> in middle-aged and elderly men. To be accurate, the process is one of <a href="../../../h/y/p/Hyperplasia.html" title="Hyperplasia">hyperplasia</a> rather than <a href="../../../o/r/g/Organ_hypertrophy.html" title="Organ hypertrophy">hypertrophy</a>, but the nomenclature is often interchangeable, even amongst urologists. In BPH, the prostate grows larger and presses against the <a href="../../../u/r/e/Urethra.html" title="Urethra">urethra</a> and <a href="../../../u/r/i/Urinary_bladder.html" title="Urinary bladder">bladder</a>, interfering with the normal flow of <a href="../../../u/r/i/Urine.html" title="Urine">urine</a>. It leads to symptoms of urinary hesitancy, frequent <a href="../../../u/r/i/Urination.html" title="Urination">urination</a>, increased risk of <a href="../../../u/r/i/Urinary_tract_infection.html" title="Urinary tract infection">urinary tract infections</a> and <a href="../../../u/r/i/Urinary_retention.html" title="Urinary retention">urinary retention</a>. There is little correlation between BPH symptoms and the presence of <a href="../../../p/r/o/Prostate_cancer.html" title="Prostate cancer">prostate cancer</a>.</p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#Symptoms"><span class="tocnumber">1</span> <span class="toctext">Symptoms</span></a></li>
<li class="toclevel-1"><a href="#Etiology"><span class="tocnumber">2</span> <span class="toctext">Etiology</span></a></li>
<li class="toclevel-1"><a href="#Diagnosis"><span class="tocnumber">3</span> <span class="toctext">Diagnosis</span></a></li>
<li class="toclevel-1"><a href="#Epidemiology"><span class="tocnumber">4</span> <span class="toctext">Epidemiology</span></a></li>
<li class="toclevel-1"><a href="#Treatment"><span class="tocnumber">5</span> <span class="toctext">Treatment</span></a>
<ul>
<li class="toclevel-2"><a href="#Medications"><span class="tocnumber">5.1</span> <span class="toctext">Medications</span></a></li>
<li class="toclevel-2"><a href="#Surgery"><span class="tocnumber">5.2</span> <span class="toctext">Surgery</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#See_also"><span class="tocnumber">6</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1"><a href="#External_links"><span class="tocnumber">7</span> <span class="toctext">External links</span></a></li>
<li class="toclevel-1"><a href="#References"><span class="tocnumber">8</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1"><a href="#Footnotes"><span class="tocnumber">9</span> <span class="toctext">Footnotes</span></a></li>
</ul>
</td>
</tr>
</table>
<p><script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script><a name="Symptoms" id="Symptoms"></a></p>
<h2><span class="editsection">[<a href="../../../b/e/n/Benign_prostatic_hyperplasia.html" title="Edit section: Symptoms">edit</a>]</span> <span class="mw-headline">Symptoms</span></h2>
<p>Benign prostatic hyperplasia symptoms are classified as obstructive or irritative. Obstructive symptoms include hesitancy, intermittency, incomplete voiding, weak urinary stream, and straining.</p>
<p>Irritative symptoms include frequency of urination, which is called nocturia when occurring at night time, and urgency (compelling need to void that can not be deferred). These obstructive and irritative symptoms are evaluated using the International Prostate Symptom Score (IPSS) questionnaire, designed to assess the severity of BPH.<sup id="_ref-0" class="reference"><a href="#_note-0" title="">[1]</a></sup></p>
<p>BPH can be a progressive disease, especially if left untreated. Incomplete voiding results in stasis of <a href="../../../b/a/c/Bacterium.html" title="Bacterium">bacteria</a> in the bladder residue and an increased risk of <a href="../../../u/r/i/Urinary_tract_infection.html" title="Urinary tract infection">urinary tract infections</a>. Urinary <a href="../../../b/l/a/Bladder_stone.html" title="Bladder stone">bladder stones</a>, are formed from the crystallisation of salts in the residual urine. <a href="../../../u/r/i/Urinary_retention.html" title="Urinary retention">Urinary retention</a>, termed acute or chronic, is another form of progression. Acute urinary retention is the inability to void, while in chronic urinary retention the residual urinary volume gradually increases, and the bladder distends. Some patients who suffer from chronic urinary retention may eventually progress to renal failure, a condition termed obstructive <a href="../../../u/r/o/Uropathy.html" title="Uropathy">uropathy</a>.</p>
<p><a name="Etiology" id="Etiology"></a></p>
<h2><span class="editsection">[<a href="../../../b/e/n/Benign_prostatic_hyperplasia.html" title="Edit section: Etiology">edit</a>]</span> <span class="mw-headline">Etiology</span></h2>
<p><a href="../../../a/n/d/Androgen.html" title="Androgen">Androgens</a> (<a href="../../../t/e/s/Testosterone.html" title="Testosterone">testosterone</a> and related <a href="../../../h/o/r/Hormone.html" title="Hormone">hormones</a>) are considered to play a permissive role in BPH by most experts. This means that androgens have to be present for BPH to occur, but do not necessarily directly cause the condition. This is supported by the fact that castrated boys do not develop BPH when they age, unlike intact men. Additionally, administering exogenous testosterone is not associated with a significant increase in the risk of BPH symptoms. <a href="../../../d/i/h/Dihydrotestosterone.html" title="Dihydrotestosterone">Dihydrotestosterone</a> (DHT), a <a href="../../../m/e/t/Metabolite.html" title="Metabolite">metabolite</a> of testosterone is a critical mediator of prostatic growth. DHT is synthesized in the prostate from circulating testosterone.</p>
<p>DHT is localized principally in the <a href="../../../s/t/r/Stromal_cell.html" title="Stromal cell">stromal cells</a>. Once synthesized, DHT can act in an <a href="../../../a/u/t/Autocrine.html" title="Autocrine">autocrine</a> fashion on the stromal cells or in <a href="../../../p/a/r/Paracrine.html" title="Paracrine">paracrine</a> fashion by diffusing into nearby <a href="../../../e/p/i/Epithelium.html" title="Epithelium">epithelial cells</a>. In both of these cell types, DHT binds to nuclear <a href="../../../a/n/d/Androgen_receptor.html" title="Androgen receptor">androgen receptors</a> and signals the <a href="../../../t/r/a/Transcription_%28genetics%29.html" title="Transcription (genetics)">transcription</a> of <a href="../../../g/r/o/Growth_factor.html" title="Growth factor">growth factors</a> that are mitogenic to the epithelial and stromal cells. The importance of DHT in causing <a href="../../../n/o/d/Nodule_%28medicine%29.html" title="Nodule (medicine)">nodular</a> hyperplasia is supported by clinical observations in which an <a href="../../../i/n/h/Inhibitor.html" title="Inhibitor">inhibitor</a> of 5α-reductase is given to men with this condition. Therapy with 5α-reductase inhibitor markedly reduces the DHT content of the prostate and in turn reduces prostate volume and, in many cases, BPH symptoms.</p>
<p>There is growing evidence that <a href="../../../e/s/t/Estrogen.html" title="Estrogen">estrogens</a> play a role in the <a href="../../../e/t/i/Etiology.html" title="Etiology">etiology</a> of BPH. This is based on the fact that BPH occurs when men generally have elevated estrogen levels and relatively reduced free testosterone levels, and when prostate tissue becomes more sensitive to estrogens and less responsive to DHT. Cells taken from the prostates of men who have BPH have been shown to grow in response to high <a href="../../../e/s/t/Estradiol.html" title="Estradiol">estradiol</a> levels with low androgens present.</p>
<p>On a microscopic level, BPH can be seen in the vast majority of men as they age, particularly over the age of 70 years, around the world. However, rates of clinically significant, symptomatic BPH vary dramatically depending on lifestyle. Men who lead a western lifestyle have a much higher incidence of symptomatic BPH than men who lead a traditional or rural lifestyle. This is confirmed by research in <a href="../../../c/h/i/China.html" title="China">China</a> showing that men in rural areas have very low rates of clinical BPH, while men living in cities adopting a western lifestyle have a skyrocketing incidence of this condition, though it is still below rates seen in the West.</p>
<p>Much work remains to be done to completely clarify the causes of BPH.</p>
<p><a name="Diagnosis" id="Diagnosis"></a></p>
<h2><span class="editsection">[<a href="../../../b/e/n/Benign_prostatic_hyperplasia.html" title="Edit section: Diagnosis">edit</a>]</span> <span class="mw-headline">Diagnosis</span></h2>
<p><a href="../../../r/e/c/Rectal_examination.html" title="Rectal examination">Rectal examination</a> (palpation of the prostate through the <a href="../../../r/e/c/Rectum.html" title="Rectum">rectum</a>) may reveal a markedly enlarged prostate. It is dependent on the skills of the doctor.</p>
<p>Often, <a href="../../../b/l/o/Blood_test.html" title="Blood test">blood tests</a> are performed to rule out prostatic malignancy: elevated <a href="../../../p/r/o/Prostate_specific_antigen.html" title="Prostate specific antigen">prostate specific antigen</a> (PSA) levels suggest prostate cancer. It has to be borne in mind that rectal examination can increase PSA levels in patients without malignancy.</p>
<p><a href="../../../m/e/d/Medical_ultrasonography.html" title="Medical ultrasonography">Ultrasound</a> examination of the testicles, prostate and kidneys is often performed, again to rule out malignancy and hydronephrosis.</p>
<p><a name="Epidemiology" id="Epidemiology"></a></p>
<h2><span class="editsection">[<a href="../../../b/e/n/Benign_prostatic_hyperplasia.html" title="Edit section: Epidemiology">edit</a>]</span> <span class="mw-headline">Epidemiology</span></h2>
<p>More than half of the men in the United States between the ages of 60 and 70 and as many as 90% between the ages of 70 and 90 have symptoms of BPH. For some men, the symptoms may be severe enough to require treatment.</p>
<p><a name="Treatment" id="Treatment"></a></p>
<h2><span class="editsection">[<a href="../../../b/e/n/Benign_prostatic_hyperplasia.html" title="Edit section: Treatment">edit</a>]</span> <span class="mw-headline">Treatment</span></h2>
<p><a name="Medications" id="Medications"></a></p>
<h3><span class="editsection">[<a href="../../../b/e/n/Benign_prostatic_hyperplasia.html" title="Edit section: Medications">edit</a>]</span> <span class="mw-headline">Medications</span></h3>
<p><a href="../../../a/l/p/Alpha_blocker.html" title="Alpha blocker">Alpha blockers</a> (α<sub>1</sub>-<a href="../../../a/d/r/Adrenergic_receptor.html" title="Adrenergic receptor">adrenergic receptor</a> <a href="../../../r/e/c/Receptor_antagonist.html" title="Receptor antagonist">antagonists</a>) provide symptomatic relief of BPH symptoms. Available drugs include <a href="../../../d/o/x/Doxazosin.html" title="Doxazosin">doxazosin</a>, <a href="../../../t/e/r/Terazosin.html" title="Terazosin">terazosin</a>, <a href="../../../a/l/f/Alfuzosin.html" title="Alfuzosin">alfuzosin</a> and <a href="../../../t/a/m/Tamsulosin.html" title="Tamsulosin">tamsulosin</a>. Older drugs, <a href="../../../p/h/e/Phenoxybenzamine.html" title="Phenoxybenzamine">phenoxybenzamine</a> and <a href="../../../p/r/a/Prazosin.html" title="Prazosin">prazosin</a> are not recommended for treatment of BPH <sup id="_ref-1" class="reference"><a href="#_note-1" title="">[2]</a></sup>. Alpha-blockers relax smooth muscle in the prostate and the bladder neck, and decrease the degree of blockage of urine flow. Alpha-blockers may cause ejaculation back into the bladder (<a href="../../../r/e/t/Retrograde_ejaculation.html" title="Retrograde ejaculation">retrograde ejaculation</a>).</p>
<p>The <a href="../../../5/-/a/5-alpha-reductase_inhibitor.html" title="5-alpha-reductase inhibitor">5α-reductase inhibitors</a> (<a href="../../../f/i/n/Finasteride.html" title="Finasteride">finasteride</a> and <a href="../../../d/u/t/Dutasteride.html" title="Dutasteride">dutasteride</a>) are another treatment option. When used together with alpha blockers a reduction of BPH progression to acute urinary retention and surgery has been noted in patients with larger prostates.<sup id="_ref-2" class="reference"><a href="#_note-2" title="">[3]</a></sup></p>
<p><br />
There is also extensive evidence of the efficacy of <i>Serenoa repens</i> (<a href="../../../s/a/w/Saw_palmetto.html" title="Saw palmetto">saw palmetto</a>) fruit extracts in alleviating mild-to-moderate BPH symptoms; a <a href="../../../s/y/s/Systematic_review.html" title="Systematic review">systematic review</a> of evidence found comparable efficacy to <a href="../../../f/i/n/Finasteride.html" title="Finasteride">finasteride</a> (Wilt <i>et al</i>., 2002). Other herbal medicines that have solid research support in systematic reviews include beta-sitosterol from <i><a href="../../../h/y/p/Hypoxis_rooperi.html" title="Hypoxis rooperi">Hypoxis rooperi</a></i> (African star grass) and <a href="../../../p/y/g/Pygeum.html" title="Pygeum">pygeum</a> (extracted from the bark of <i><a href="../../../p/r/u/Prunus_africana.html" title="Prunus africana">Prunus africana</a></i>), while there is less substantial support for the efficacy of <i><a href="../../../c/u/c/Cucurbita_pepo.html" title="Cucurbita pepo">Cucurbita pepo</a></i> (pumpkin) seed and <i><a href="../../../u/r/t/Urtica_dioica.html" title="Urtica dioica">Urtica dioica</a></i> (<a href="../../../s/t/i/Stinging_nettle.html" title="Stinging nettle">stinging nettle</a>) root (Wilt <i>et al</i>., 2000). At least one double-blind trial has also supported the efficacy of rye flower pollen (Buck, <i>et al</i>., 1990).</p>
<p><a href="../../../s/i/l/Sildenafil.html" title="Sildenafil">Sildenafil</a> shows some symptomatic relief, suggesting a possible common etiology with <a href="../../../e/r/e/Erectile_disfunction.html" title="Erectile disfunction">erectile disfunction</a><sup id="_ref-3" class="reference"><a href="#_note-3" title="">[4]</a></sup>.</p>
<p><a name="Surgery" id="Surgery"></a></p>
<h3><span class="editsection">[<a href="../../../b/e/n/Benign_prostatic_hyperplasia.html" title="Edit section: Surgery">edit</a>]</span> <span class="mw-headline">Surgery</span></h3>
<p>If medical treatment fails, <a href="../../../t/r/a/Transurethral_resection_of_prostate.html" title="Transurethral resection of prostate">transurethral resection of prostate</a> (TURP) surgery may need to be performed. This involves removing (part of) the prostate through the <a href="../../../u/r/e/Urethra.html" title="Urethra">urethra</a>. There are also a number of new methods for reducing the size of an enlarged prostate, some of which have not been around long enough to fully establish their safety or side effects. These include various methods to destroy or remove part of the excess tissue while trying to avoid damaging what's left. Transurethral electrovaporization of the prostate (TVP), laser TURP, visual laser ablation (VLAP), TransUrethral Microwave ThermoTherapy (TUMT), <a href="../../../t/r/a/Transurethral_needle_ablation_of_the_prostate.html" title="Transurethral needle ablation of the prostate">TransUrethral Needle Ablation</a> (TUNA), ethanol injection, and others are studied as alternatives.</p>
<p>Newer techniques involving lasers in urology have emerged in the last 5-10 years. Starting with the VLAP technique involving the <a href="../../../y/a/g/Nd%7EYAG_laser_b316.html" title="Nd:YAG laser">Nd:YAG laser</a> with contact on the prostatic tissue. A similar technology called Photoselective Vaporization of the Prostate (PVP) with the GreenLight (KTP) laser have emerged very recently. This procedure involves a high powered 80 Watt KTP laser with a 550 micrometre laser fiber inserted into the prostate. This fiber has an internal reflection with a 70 degree deflecting angle. It is used to vaporize the tissue to the prostatic capsule. KTP lasers target haemoglobin as the chromophore and have typically have a penetration depth of 2.0mm (four times deeper than holmium).</p>
<p>Another procedure termed Holmium Laser Ablation of the Prostate (HoLAP) has also been gaining acceptance around the world. Like KTP the delivery device for HoLAP procedures is a 550um disposable side-firing fiber that directs the beam from a high powered 100 Watt laser at a 70degree from the fiber axis. The holmium wavelength is 2,140nm, which falls within the infrared portion of the spectrum and is invisible to the naked eye. Where KTP relies on haemoglobin as a chromophore, water within the target tissue is the chromophore for Holmium lasers. The pentration depth of Holmium lasers is &lt;0.5mm avoiding complications associated with tissue necrosis often found with the deeper penetration and lower peak powers of KTP.</p>
<p>Both wavelengths, KTP and Holmium, ablate approximately one to two grams of tissue per minute.</p>
<p><a name="See_also" id="See_also"></a></p>
<h2><span class="editsection">[<a href="../../../b/e/n/Benign_prostatic_hyperplasia.html" title="Edit section: See also">edit</a>]</span> <span class="mw-headline">See also</span></h2>
<ul>
<li><a href="../../../p/r/o/Prostate_cancer.html" title="Prostate cancer">Prostate cancer</a></li>
<li><a href="../../../u/r/i/Urinary_retention.html" title="Urinary retention">Urinary retention</a></li>
<li><a href="../../../u/v/u/Uvula_of_urinary_bladder.html" title="Uvula of urinary bladder">Uvula of urinary bladder</a></li>
</ul>
<p><a name="External_links" id="External_links"></a></p>
<h2><span class="editsection">[<a href="../../../b/e/n/Benign_prostatic_hyperplasia.html" title="Edit section: External links">edit</a>]</span> <span class="mw-headline">External links</span></h2>
<ul>
<li><a href="http://www.holmiumforbph.com/index.html" class="external text" title="http://www.holmiumforbph.com/index.html" rel="nofollow">Holmium for BPH</a></li>
</ul>
<p><a name="References" id="References"></a></p>
<h2><span class="editsection">[<a href="../../../b/e/n/Benign_prostatic_hyperplasia.html" title="Edit section: References">edit</a>]</span> <span class="mw-headline">References</span></h2>
<ul>
<li>Buck AC, Cox R, Rees RWM, et al. (1990) Treatment of outflow tract obstruction due to benign prostatic hyperplasia with the pollen extract, Cernilton. A double-blind placebo-controlled study <i>Br J Urol</i> 66:398-404 (<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=1699628&amp;query_hl=1&amp;itool=pubmed_docsum" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=1699628&amp;query_hl=1&amp;itool=pubmed_docsum" rel="nofollow">Medline abstract</a>)</li>
<li>Kirby R, McConnell J, et al. (eds) (1996) <i>Textbook of Benign Prostatic Hyperplasia</i> (Oxford: Isis Medical Media) <a href="../../../b/o/o/Special%7EBooksources_ed7b.html" class="internal">ISBN 1-899066-24-1</a></li>
<li>Wilt TJ, Ishani A, MacDonald R, (2002). Serenoa repens for benign prostatic hyperplasia. <i><a href="../../../c/o/c/Cochrane_Library_0637.html" title="Cochrane Library">Cochrane Database Syst Rev</a></i> <b>2002</b> (3), CD001423. (<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12137626" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12137626" rel="nofollow">Medline abstract</a>)</li>
<li>Wilt TJ, Ishani A, Rutks I, MacDonald R (2000) Phytotherapy for benign prostatic hyperplasia <i>Public Health Nutr</i> 3(4A):459-72 (<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11276294&amp;query_hl=5&amp;itool=pubmed_docsum" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11276294&amp;query_hl=5&amp;itool=pubmed_docsum" rel="nofollow">Medline abstract</a>)</li>
<li>Yarnell E (2001) <i>Naturopathic Urology and Men's Health</i> (Wenatchee, WA: Healing Mountain Publishing) <a href="../../../b/o/o/Special%7EBooksources_ed7b.html" class="internal">ISBN 0-9741178-3-8</a> <a href="http://www.healingmountainpublishing.com" class="external autonumber" title="http://www.healingmountainpublishing.com" rel="nofollow">[1]</a></li>
</ul>
<p><a name="Footnotes" id="Footnotes"></a></p>
<h2><span class="editsection">[<a href="../../../b/e/n/Benign_prostatic_hyperplasia.html" title="Edit section: Footnotes">edit</a>]</span> <span class="mw-headline">Footnotes</span></h2>
<ol class="references">
<li id="_note-0"><b><a href="#_ref-0" title="">^</a></b> Barry MJ, Fowler FJ Jr, O'Leary MP, <i>et al</i> (1992). The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. <i>J Urol</i> <b>148(5)</b>: 1549-57. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=1279218" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=1279218">PMID 1279218</a></li>
<li id="_note-1"><b><a href="#_ref-1" title="">^</a></b> AUA Practice Guidelines Committee.AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations. <i>J Urol</i> <b>170(2 Pt 1)</b>: 530-47. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12853821" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12853821">PMID 12853821</a></li>
<li id="_note-2"><b><a href="#_ref-2" title="">^</a></b> Kaplan SA, McConnell JD, Roehrborn CG, <i>et al</i> (2006). Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 ml or greater. <i>J Urol</i> <b>175(1)</b>: 217-20. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16406915" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16406915">PMID 16406915</a>.</li>
<li id="_note-3"><b><a href="#_ref-3" title="">^</a></b> McVary KT, Monnig W, Camps JL Jr, <i>et al</i> (2007). Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double-blind trial. <i>J Urol</i> <b>177(3)</b>&#160;:1071-7. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=17296414" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=17296414">PMID 17296414</a></li>
</ol>
<table class="navbox collapsible" style="margin: auto;">
<tr>
<th colspan="2" style="text-align:center;">
<div class="noprint plainlinksneverexpand" style="background-color:transparent; padding:0; font-weight:normal; font-size:xx-small; color:#000000; white-space:nowrap; float:left;width:6em;text-align:left;"><a href="../../../u/r/o/Template%7EUrologicals_72db.html" title="Template:Urologicals"><span title="View this template">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<span style="color: #002bb8;" title="Discussion about this template">d</span>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org../../../u/r/o/Template%7EUrologicals_72db.html" class="external text" title="http://en.wikipedia.org../../../u/r/o/Template%7EUrologicals_72db.html" rel="nofollow"><span style="color: #002bb8;" title="You can edit this template. Please use the preview button before saving.">e</span></a></div>
<a href="../../../u/r/o/Urologicals.html" title="Urologicals">Urologicals</a> (<a href="../../../a/t/c/ATC_code_G04_fc7b.html" title="ATC code G04">G04</a>)</th>
</tr>
<tr>
<th style=""><a href="../../../a/c/i/Acidifier.html" title="Acidifier">Acidifiers</a></th>
<td><a href="../../../a/m/m/Ammonium_chloride.html" title="Ammonium chloride">Ammonium chloride</a>, <a href="../../../c/a/l/Calcium_chloride.html" title="Calcium chloride">Calcium chloride</a></td>
</tr>
<tr>
<th style=""><a href="../../../u/r/i/Urinary.html" title="Urinary">Urinary</a> <a href="../../../a/n/t/Antispasmodic.html" title="Antispasmodic">antispasmodics</a></th>
<td><a href="../../../d/a/r/Darifenacin.html" title="Darifenacin">Darifenacin</a>, Emepronium, <a href="../../../f/l/a/Flavoxate.html" title="Flavoxate">Flavoxate</a>, Meladrazine, <a href="../../../o/x/y/Oxybutynin.html" title="Oxybutynin">Oxybutynin</a>, Propiverine, <a href="../../../s/o/l/Solifenacin.html" title="Solifenacin">Solifenacin</a>, Terodiline, <a href="../../../t/o/l/Tolterodine.html" title="Tolterodine">Tolterodine</a>, <a href="../../../t/r/o/Trospium.html" title="Trospium">Trospium</a></td>
</tr>
<tr>
<th style="">For <a href="../../../e/r/e/Erectile_dysfunction.html" title="Erectile dysfunction">erectile dysfunction</a></th>
<td><a href="../../../a/l/p/Alprostadil.html" title="Alprostadil">Alprostadil</a>, <a href="../../../a/p/o/Apomorphine.html" title="Apomorphine">Apomorphine</a>, Avanafil, Moxisylyte, <a href="../../../p/a/p/Papaverine.html" title="Papaverine">Papaverine</a>, <a href="../../../p/h/e/Phentolamine.html" title="Phentolamine">Phentolamine</a>, <a href="../../../s/i/l/Sildenafil.html" title="Sildenafil">Sildenafil</a>, <a href="../../../t/a/d/Tadalafil.html" title="Tadalafil">Tadalafil</a>, Udenafil, <a href="../../../v/a/r/Vardenafil.html" title="Vardenafil">Vardenafil</a>, Vendafidel, <a href="../../../y/o/h/Yohimbine.html" title="Yohimbine">Yohimbine</a></td>
</tr>
<tr>
<th style="">Other urologicals</th>
<td><a href="../../../a/c/e/Acetohydroxamic_acid.html" title="Acetohydroxamic acid">Acetohydroxamic acid</a>, <a href="../../../c/o/l/Collagen.html" title="Collagen">Collagen</a>, <a href="../../../d/i/m/Dimethyl_sulfoxide.html" title="Dimethyl sulfoxide">Dimethyl sulfoxide</a>, <a href="../../../m/a/g/Magnesium_hydroxide.html" title="Magnesium hydroxide">Magnesium hydroxide</a>, <a href="../../../p/h/e/Phenazopyridine.html" title="Phenazopyridine">Phenazopyridine</a>, <a href="../../../p/h/e/Phenyl_salicylate.html" title="Phenyl salicylate">Phenyl salicylate</a>, <a href="../../../s/u/c/Succinimide.html" title="Succinimide">Succinimide</a></td>
</tr>
<tr>
<th style="">For <a href="../../../b/e/n/Benign_prostatic_hypertrophy.html" title="Benign prostatic hypertrophy">benign prostatic hypertrophy</a></th>
<td><b><a href="../../../5/-/a/5-alpha-reductase_inhibitor.html" title="5-alpha-reductase inhibitor">5α-reductase inhibitors</a>:</b> <a href="../../../d/u/t/Dutasteride.html" title="Dutasteride">Dutasteride</a>, <a href="../../../f/i/n/Finasteride.html" title="Finasteride">Finasteride</a><br />
<p><b><a href="../../../a/l/p/Alpha_blocker.html" title="Alpha blocker">Alpha blockers</a>:</b> <a href="../../../a/l/f/Alfuzosin.html" title="Alfuzosin">Alfuzosin</a>, <a href="../../../d/o/x/Doxazosin.html" title="Doxazosin">Doxazosin</a>, <a href="../../../t/a/m/Tamsulosin.html" title="Tamsulosin">Tamsulosin</a>, <a href="../../../t/e/r/Terazosin.html" title="Terazosin">Terazosin</a><br /></p>
<b><a href="../../../h/e/r/Herb.html" title="Herb">Herbals</a>:</b> <i><a href="../../../p/y/g/Pygeum.html" title="Pygeum">Pygeum africanum</a></i>, <i><a href="../../../s/a/w/Saw_Palmetto_3d0c.html" title="Saw Palmetto">Serenoa repens</a></i></td>
</tr>
</table>

<!-- 
Pre-expand include size: 14487 bytes
Post-expand include size: 8015 bytes
Template argument size: 4038 bytes
Maximum: 2048000 bytes
-->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org../../../b/e/n/Benign_prostatic_hyperplasia.html">http://en.wikipedia.org../../../b/e/n/Benign_prostatic_hyperplasia.html</a>"</div>
	    <div id="catlinks"><p class='catlinks'><a href="../../../c/a/t/Special%7ECategories_101d.html" title="Special:Categories">Categories</a>: <span dir='ltr'><a href="../../../a/n/d/Category%7EAndrology_f5ba.html" title="Category:Andrology">Andrology</a></span> | <span dir='ltr'><a href="../../../u/r/o/Category%7EUrology_a0b7.html" title="Category:Urology">Urology</a></span></p></div>	    <!-- end content -->
	    <div class="visualClear"></div>
	  </div>
	</div>
      </div>
      <div id="column-one">
	<div id="p-cactions" class="portlet">
	  <h5>Views</h5>
	  <ul>
	    <li id="ca-nstab-main"
	       class="selected"	       ><a href="../../../b/e/n/Benign_prostatic_hyperplasia.html">Article</a></li><li id="ca-talk"
	       	       ><a href="../../../b/e/n/Talk%7EBenign_prostatic_hyperplasia_240e.html">Discussion</a></li><li id="ca-current"
	       	       ><a href="http://en.wikipedia.org/wiki/Benign_prostatic_hyperplasia">Current revision</a></li>	  </ul>
	</div>
	<div class="portlet" id="p-logo">
	  <a style="background-image: url(../../../images/wiki-en.png);"
	    href="../../../index.html"
	    title="Main Page"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
		<div class='portlet' id='p-navigation'>
	  <h5>Navigation</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-Main-page"><a href="../../../index.html">Main page</a></li>
	     	      <li id="n-Contents"><a href="../../../c/o/n/Wikipedia%7EContents_3181.html">Contents</a></li>
	     	      <li id="n-Featured-content"><a href="../../../f/e/a/Wikipedia%7EFeatured_content_24ba.html">Featured content</a></li>
	     	      <li id="n-currentevents"><a href="../../../c/u/r/Portal%7ECurrent_events_bb60.html">Current events</a></li>
	     	    </ul>
	  </div>
	</div>
		<div class='portlet' id='p-interaction'>
	  <h5>interaction</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-About-Wikipedia"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html">About Wikipedia</a></li>
	     	      <li id="n-portal"><a href="../../../c/o/m/Wikipedia%7ECommunity_Portal_6a3c.html">Community portal</a></li>
	     	      <li id="n-contact"><a href="../../../c/o/n/Wikipedia%7EContact_us_afd6.html">Contact us</a></li>
	     	      <li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Fundraising">Make a donation</a></li>
	     	      <li id="n-help"><a href="../../../c/o/n/Help%7EContents_22de.html">Help</a></li>
	     	    </ul>
	  </div>
	</div>
		<div id="p-search" class="portlet">
	  <h5><label for="searchInput">Search</label></h5>
	  <div id="searchBody" class="pBody">
	    <form action="javascript:goToStatic(3)" id="searchform"><div>
	      <input id="searchInput" name="search" type="text"
	        accesskey="f" value="" />
	      <input type='submit' name="go" class="searchButton" id="searchGoButton"
	        value="Go" />
	    </div></form>
	  </div>
	</div>
	<div id="p-lang" class="portlet">
	  <h5>In other languages</h5>
	  <div class="pBody">
	    <ul>
	      	      <li>
	      <a href="../../../../de/b/e/n/Benigne_Prostatahyperplasie_6a5a.html">Deutsch</a>
	      </li>
	      	      <li>
	      <a href="../../../../es/h/i/p/Hipertrofia_benigna_de_pr%C3%B3stata.html">Español</a>
	      </li>
	      	      <li>
	      <a href="../../../../fr/h/y/p/Hypertrophie_b%C3%A9nigne_de_la_prostate.html">Français</a>
	      </li>
	      	      <li>
	      <a href="../../../../it/i/p/e/Ipertrofia_prostatica_benigna.html">Italiano</a>
	      </li>
	      	      <li>
	      <a href="../../../../nl/b/e/n/Benigne_prostaathypertrofie.html">Nederlands</a>
	      </li>
	      	      <li>
	      <a href="../../../../ja/%E5%89%8D/%E7%AB%8B/%E8%85%BA/%E5%89%8D%E7%AB%8B%E8%85%BA%E8%82%A5%E5%A4%A7%E7%97%87.html">日本語</a>
	      </li>
	      	      <li>
	      <a href="../../../../pl/%C5%82/a/g/%C5%81agodny_przerost_gruczo%C5%82u_krokowego.html">Polski</a>
	      </li>
	      	      <li>
	      <a href="../../../../pt/h/i/p/Hiperplasia_benigna_da_pr%C3%B3stata.html">Português</a>
	      </li>
	      	      <li>
	      <a href="../../../../ru/%D0%B0/%D0%B4/%D0%B5/%D0%90%D0%B4%D0%B5%D0%BD%D0%BE%D0%BC%D0%B0_%D0%BF%D1%80%D0%BE%D1%81%D1%82%D0%B0%D1%82%D1%8B.html">Русский</a>
	      </li>
	      	      <li>
	      <a href="../../../../vi/u/_/x/U_x%C6%A1_ti%E1%BB%81n_li%E1%BB%87t_tuy%E1%BA%BFn.html">Tiếng Việt</a>
	      </li>
	      	      <li>
	      <a href="../../../../zh/%E8%89%AF/%E6%80%A7/%E5%89%8D/%E8%89%AF%E6%80%A7%E5%89%8D%E5%88%97%E8%85%BA%E5%A2%9E%E7%94%9F%E7%97%87.html">中文</a>
	      </li>
	      	    </ul>
	  </div>
	</div>
	      </div><!-- end of the left (by default at least) column -->
      <div class="visualClear"></div>
      <div id="footer">
    <div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="../../../skins/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>	<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="../../../images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>	<ul id="f-list">
	  	  	  <li id="f-credits">This page was last modified 13:26, 21 March 2007 by Anonymous user(s) of Wikipedia. Based on work by Wikipedia user(s) <a href="../../../h/u/1/User%7EHu12_d0ca.html" title="User:Hu12">Hu12</a>, Munblog, <a href="../../../h/a/i/User%7EHaim_Berman_8a5a.html" title="User:Haim Berman">Haim Berman</a>, <a href="../../../d/e/r/User%7EDerwig_2520.html" title="User:Derwig">Derwig</a>, <a href="../../../j/f/b/User%7EJfbcubed_94a2.html" title="User:Jfbcubed">Jfbcubed</a>, <a href="../../../r/e/i/User%7ERei-bot_e279.html" title="User:Rei-bot">Rei-bot</a>, <a href="../../../d/a/v/User%7EDavidruben_76a6.html" title="User:Davidruben">Davidruben</a>, <a href="../../../j/f/d/User%7EJfdwolff_9ea6.html" title="User:Jfdwolff">Jfdwolff</a>, Papte, <a href="../../../c/l/i/User%7EClicketyclack_8af2.html" title="User:Clicketyclack">Clicketyclack</a>, <a href="../../../s/r/l/User%7ESrleffler_03c1.html" title="User:Srleffler">Srleffler</a>, Tokingjedi, <a href="../../../a/r/c/User%7EArcadian_5c4b.html" title="User:Arcadian">Arcadian</a>, Tina0157h7, <a href="../../../l/o/r/User%7ELordmetroid_b969.html" title="User:Lordmetroid">Lordmetroid</a>, <a href="../../../k/j/k/User%7EKjkolb_e2d0.html" title="User:Kjkolb">Kjkolb</a>, <a href="../../../b/l/u/User%7EBluebot_e595.html" title="User:Bluebot">Bluebot</a>, Gobstopper, <a href="../../../n/e/t/User%7ENetsnipe_10c5.html" title="User:Netsnipe">Netsnipe</a>, <a href="../../../k/n/o/User%7EKnowledgeOfSelf_7104.html" title="User:KnowledgeOfSelf">KnowledgeOfSelf</a>, Johnshopkinshealthalerts, <a href="../../../t/h/u/User%7EThunderhead_3955.html" title="User:Thunderhead">Thunderhead</a>, <a href="../../../t/h/i/User%7EThijs%21bot_bdf4.html" title="User:Thijs!bot">Thijs!bot</a>, <a href="../../../b/e/m/User%7EBemoeial_caf3.html" title="User:Bemoeial">Bemoeial</a>, <a href="../../../k/i/r/User%7EKirk_Hilliard_a461.html" title="User:Kirk Hilliard">Kirk Hilliard</a>, <a href="../../../k/i/n/User%7EKinu_5ebb.html" title="User:Kinu">Kinu</a>, <a href="../../../t/e/w/User%7ETewfik_396b.html" title="User:Tewfik">Tewfik</a>, <a href="../../../h/t/a/User%7EHTait_4916.html" title="User:HTait">HTait</a>, <a href="../../../m/a/c/User%7EMac_Davis_1c34.html" title="User:Mac Davis">Mac Davis</a>, <a href="../../../d/r/a/User%7EDragonflySixtyseven_c6ee.html" title="User:DragonflySixtyseven">DragonflySixtyseven</a>, ProstaLund, <a href="../../../y/u/r/User%7EYurikBot_b393.html" title="User:YurikBot">YurikBot</a>, <a href="../../../m/a/x/User%7EMaxxicum_348e.html" title="User:Maxxicum">Maxxicum</a>, <a href="../../../b/o/b/User%7EBobblewik_fbc0.html" title="User:Bobblewik">Bobblewik</a>, <a href="../../../l/e/x/User%7ELexicon_cf83.html" title="User:Lexicon">Lexicon</a>, <a href="../../../e/r/i/User%7EEric_Yarnell_e5aa.html" title="User:Eric Yarnell">Eric Yarnell</a>, Phidelt602, Ndspider, <a href="../../../l/i/g/User%7ELigulembot_623f.html" title="User:Ligulembot">Ligulembot</a>, <a href="../../../p/h/8/User%7EPh89_0579.html" title="User:Ph89">Ph89</a>, <a href="../../../d/a/v/User%7EDavid.Throop_ff18.html" title="User:David.Throop">David.Throop</a>, <a href="../../../a/m/t/User%7EAmtiss_74f1.html" title="User:Amtiss">Amtiss</a>, <a href="../../../h/s/w/User%7EHswapnil_14e5.html" title="User:Hswapnil">Hswapnil</a>, <a href="../../../h/u/j/User%7EHuji_94bb.html" title="User:Huji">Huji</a>, <a href="../../../p/l/u/User%7EPlugwash_0129.html" title="User:Plugwash">Plugwash</a>, <a href="../../../a/h/o/User%7EAhoerstemeier_88c8.html" title="User:Ahoerstemeier">Ahoerstemeier</a>, <a href="../../../r/i/c/User%7ERich_Farmbrough_7642.html" title="User:Rich Farmbrough">Rich Farmbrough</a>, <a href="../../../s/f/d/User%7ESfdan_f912.html" title="User:Sfdan">Sfdan</a>, <a href="../../../e/l/e/User%7EEleassar777_7cf2.html" title="User:Eleassar777">Eleassar777</a>, <a href="../../../c/a/n/User%7ECanisRufus_0875.html" title="User:CanisRufus">CanisRufus</a>, <a href="../../../t/e/c/User%7ETechelf_1565.html" title="User:Techelf">Techelf</a>, <a href="../../../p/n/e/User%7EPne_05d6.html" title="User:Pne">Pne</a> and <a href="../../../b/r/y/User%7EBryan_Derksen_3ce8.html" title="User:Bryan Derksen">Bryan Derksen</a>.</li>	  <li id="f-copyright">All text is available under the terms of the <a class='internal' href="../../../t/e/x/Wikipedia%7EText_of_the_GNU_Free_Documentation_License_702a.html" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="../../../c/o/p/Wikipedia%7ECopyrights_92c4.html" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc</a>., a US-registered <a class='internal' href="../../../5/0/1/501%28c%29.html#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="../../../n/o/n/Non-profit_organization.html" title="Non-profit organization">nonprofit</a> <a href="../../../c/h/a/Charitable_organization.html" title="Charitable organization">charity</a>.<br /></li>	  <li id="f-about"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html" title="Wikipedia:About">About Wikipedia</a></li>	  <li id="f-disclaimer"><a href="../../../g/e/n/Wikipedia%7EGeneral_disclaimer_3e44.html" title="Wikipedia:General disclaimer">Disclaimers</a></li>	  	</ul>
      </div>
    </div>
  </body>
</html>
